Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Scott Lucia

Showing results (41-50 of 168) with videos related to

Pageof 17
Sort By:
Kidney International|March 29, 2002
Caspases, Bcl-2 proteins and apoptosis in autosomal-dominant polycystic kidney diseaseTevfik Ecder, Vyacheslav Y Melnikov, Melinda Stanley, et al.
The Prostate|January 1, 2008
Finasteride, prostate cancer, and weight gain: evidence for genetic or environmental factors that affect cancer outcomes during finasteride treatmentYoonJu Song, Catherine Tangen, Phyllis Goodman, et al.
Journal of Neuro-Oncology|January 19, 2019
Prostatic adenocarcinoma CNS parenchymal and dural metastases: alterations in ERG, CHD1 and MAP3K7 expressionD Ryan Ormond, B K Kleinschmidt-DeMasters, Daniel Cavalcante, et al.
The Journal of Urology|April 2, 2015
Prostate Biopsy Markers of Inflammation are Associated with Risk of Clinical Progression of Benign Prostatic Hyperplasia: Findings from the MTOPS StudyKathleen C Torkko, R Storey Wilson, Elizabeth E Smith, et al.
Technology in Cancer Research & Treatment|October 7, 2016
Deflection Analysis of Different Needle Designs for Prostate Biopsy and Focal TherapyNelson N Stone, Vladimir Mouraviev, David Schechter, et al.
Reviews in Urology|September 21, 2006
Chemoprevention strategies in the prostate: an overviewGary J Kelloff, Howard R Higley, Michael K Brawer, et al.
Cancer Epidemiology|October 23, 2019
Variations in prostate biopsy recommendation and acceptance confound evaluation of risk factors for prostate cancer: Examining race and BMICatherine M Tangen, Jeannette Schenk, Cathee Till, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 8, 2002
Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinomaRainer Lehner, M Scott Lucia, Elke A Jarboe, et al.
Lancet (London, England)|January 27, 2012
Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trialNeil E Fleshner, M Scott Lucia, Blair Egerdie, et al.
Urology Practice|August 4, 2023
Moving Forward the State of the Art in Prostate Cancer Treatment: Targeted Focal TherapyE David Crawford, Kyle O Rove, Nelson N Stone, et al.
Pageof 17

Showing results (41-50 of 168) with videos related to

Sort By:
Pageof 17
Kidney International|March 29, 2002
Caspases, Bcl-2 proteins and apoptosis in autosomal-dominant polycystic kidney diseaseTevfik Ecder, Vyacheslav Y Melnikov, Melinda Stanley, et al.
The Prostate|January 1, 2008
Finasteride, prostate cancer, and weight gain: evidence for genetic or environmental factors that affect cancer outcomes during finasteride treatmentYoonJu Song, Catherine Tangen, Phyllis Goodman, et al.
Journal of Neuro-Oncology|January 19, 2019
Prostatic adenocarcinoma CNS parenchymal and dural metastases: alterations in ERG, CHD1 and MAP3K7 expressionD Ryan Ormond, B K Kleinschmidt-DeMasters, Daniel Cavalcante, et al.
The Journal of Urology|April 2, 2015
Prostate Biopsy Markers of Inflammation are Associated with Risk of Clinical Progression of Benign Prostatic Hyperplasia: Findings from the MTOPS StudyKathleen C Torkko, R Storey Wilson, Elizabeth E Smith, et al.
Technology in Cancer Research & Treatment|October 7, 2016
Deflection Analysis of Different Needle Designs for Prostate Biopsy and Focal TherapyNelson N Stone, Vladimir Mouraviev, David Schechter, et al.
Reviews in Urology|September 21, 2006
Chemoprevention strategies in the prostate: an overviewGary J Kelloff, Howard R Higley, Michael K Brawer, et al.
Cancer Epidemiology|October 23, 2019
Variations in prostate biopsy recommendation and acceptance confound evaluation of risk factors for prostate cancer: Examining race and BMICatherine M Tangen, Jeannette Schenk, Cathee Till, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 8, 2002
Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinomaRainer Lehner, M Scott Lucia, Elke A Jarboe, et al.
Lancet (London, England)|January 27, 2012
Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trialNeil E Fleshner, M Scott Lucia, Blair Egerdie, et al.
Urology Practice|August 4, 2023
Moving Forward the State of the Art in Prostate Cancer Treatment: Targeted Focal TherapyE David Crawford, Kyle O Rove, Nelson N Stone, et al.
Pageof 17